|
13.05.25 - 08:54
|
XFRA: MFJ: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
POLYNOVO LTD MFJ AU000000PNV0
AB/FROM ONWARDS 13.05.2025 08:47 CET...
|
|
12.05.25 - 09:09
|
XFRA: MFJ: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
POLYNOVO LTD MFJ AU000000PNV0 BAW/UFN...
|
|
|
|
|
|
|
|
|
|
|
06.03.25 - 16:39
|
Spectral AI Completes Three Device Installations in Australia (GlobeNewswire EN)
|
|
DALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of the installation of three of the DeepView System devices in Australia. The Company, in partnership with global medical device company and burn wound therapy leader PolyNovo Limited (“PolyNovo”). The Company was able to utilize the Australian Special Access Scheme (SAS) to deploy three DeepView Systems at the Concord Repatriation General Hospital in Sydney, the Royal Adelaide Hospital in Adelaide and the Fiona Stanley Hospital in Murdoch (Perth). The installation of these devices will support the Company's eventual commercial roll-out based on clinician evaluations and experiences using the device....
|
|
|
|
|
|
|
|
|